| 43.42 Delayed Data As of Oct 21 |  +0.46 / +1.07%Today’s Change | 21.98 Today|||52-Week Range 82.49 | +50.66% Year-to-Date |
| Previous close | 42.96 |
| Today’s open | 43.11 |
| Day’s range | 42.36 - 44.12 |
| Volume | 275,094 |
| Average volume (3 months) | 644,347 |
| Market cap | $1.9B |
| Earnings growth (last year) | +20.50% |
| Earnings growth (this year) | -32.51% |
| Earnings growth (next 5 years) | -26.60% |
| Revenue growth (last year) | -13.91% |
| P/E ratio | NM |
| Price/Sales | 91.03 |
| Price/Book | 8.93 |
| Today’s change | Today’s % change | |
|---|---|---|
| DCPHDeciphera Pharmaceut... | +0.79 | +2.31% |
| XNCRXencor Inc | +1.17 | +3.34% |
| HRTXHeron Therapeutics I... | +0.59 | +3.23% |
| ZLABZai Lab Ltd | -1.21 | -3.55% |
| Next reporting date | December 9, 2019 |
| EPS forecast (this quarter) | -$0.81 |
| Annual revenue (last year) | $11.3M |
| Annual profit (last year) | -$83.3M |
| Net profit margin | -738.25% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Amsterdam, Noord-holland |
